FDA Approved: MONTELUKAST — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental application for Montelukast from Sandoz Inc, authorizing the generic montelukast product under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Asthma

Drugs mentioned

• Montelukast (Montelukast)

Snippet

SUPPL AP for MONTELUKAST (MONTELUKAST)